{"DataElement":{"publicId":"3915552","version":"1","preferredName":"Tumor Marker CA-19-9 Upper Limit of Normal Value","preferredDefinition":"The number that represents the reported high limit of the cancer antigen 19-9 test reference range.","longName":"2192294v1.0:3628762v1.0","context":"NCIP","contextVersion":"1","DataElementConcept":{"publicId":"2192294","version":"1","preferredName":"Tumor Marker CA-19-9 Test","preferredDefinition":"information related to a test for tumor marker CA-19-9.","longName":"TMMKR_CA-19-9_TST","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2443094","version":"1","preferredName":"Tumor Marker","preferredDefinition":"A substance sometimes found in an increased amount in the blood, other body fluids, or tissues and which may mean that a certain type of cancer is in the body. Examples of tumor markers include CA 125 (ovarian cancer), CA 15-3 (breast cancer), CEA (ovarian, lung, breast, pancreas, and gastrointestinal tract cancers), and PSA (prostate cancer). Also called biomarker.","longName":"C17220","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Tumor Marker","conceptCode":"C17220","definition":"A substance present in or produced by a tumor or by the host, that can be used for differentiating neoplastic from normal tissue based on measurements in body fluids, secretions, cells, and/or tissues. Markers are used in diagnosis, staging and prognosis of cancer, provide an estimation of tumor burden, and serve for monitoring effects of therapy, detecting recurrence, localization of tumors, and screening in general populations.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0A400EF7-3DF6-3538-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-01-16","endDate":null,"createdBy":"PWEST","dateCreated":"2006-01-16","modifiedBy":"ONEDATA","dateModified":"2006-01-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2207090","version":"3","preferredName":"CA19-9 Antigen Test","preferredDefinition":"CA19-9 is a carbohydrate often found in elevated levels in patients with carcinoma of the pancreas or gastrointestinal tract.:A procedure for critical evaluation; a means of determining the presence, quality, or truth of something.","longName":"CA19-9","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"CA19-9 Antigen","conceptCode":"C327","definition":"CA 19-9 is a fucosylated glycosphingolipid carbohydrate antigen that is soluble and is adsorbed to erythrocytes and to many adenocarcinomas of the digestive tract, especially pancreatic tumors. By structure CA 19-9 is related to the Lewis blood group antigens.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Laboratory Procedure","conceptCode":"C25294","definition":"Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1C234BF7-4C07-0FD0-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-08-29","endDate":null,"createdBy":"DWARZEL","dateCreated":"2006-08-29","modifiedBy":"ONEDATA","dateModified":"2006-08-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E915505A-2B71-0390-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-11-17","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-11-17","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":"Updated to use fixed NCI Concept for CA19-19 Antigen with correct NCI Thesaurus mapping.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3628762","version":"1","preferredName":"Upper Limit of Normal 2 Decimal Place Value","preferredDefinition":"The top value of the range of statistical characteristics that are supposed to represent accepted standard, non-pathological pattern for particular laboratory result or other quantitative parameter._A number with no fractional part, including the negative and positive numbers as well as zero.::2_An indication of the specific number of digits to be expected to the right of the decimal point in a line of numbers._A numerical quantity measured or assigned or computed.","longName":"3628762v1.0","context":"NCIP","contextVersion":"1","type":"Non-enumerated","dataType":"NUMBER","minLength":"2","maxLength":"4","minValue":null,"maxValue":null,"decimalPlace":"2","PermissibleValues":[],"ConceptualDomain":{"publicId":"2008557","version":"1","preferredName":"Lab Results","preferredDefinition":"the results of laboratory tests.","longName":"LAB_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2CFBA7D-D009-7227-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3628761","version":"1","preferredName":"Upper Limit of Normal Integer::2 Decimal Place Value","preferredDefinition":"The top value of the range of statistical characteristics that are supposed to represent accepted standard, non-pathological pattern for particular laboratory result or other quantitative parameter.:A number with no fractional part, including the negative and positive numbers as well as zero.::2:An indication of the specific number of digits to be expected to the right of the decimal point in a line of numbers.:A numerical quantity measured or assigned or computed.","longName":"C25706:C45255::2:C42646:C25712","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Upper Limit of Normal","conceptCode":"C25706","definition":"The top value of the range of statistical characteristics that are supposed to represent accepted standard, non-pathological pattern for particular laboratory result or other quantitative parameter.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Integer","conceptCode":"C45255","definition":"A number with no fractional part, including the negative and positive numbers as well as zero.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Decimal Place","conceptCode":"C42646","definition":"An indication of the specific number of digits to be expected to the right of the decimal point in a line of numbers.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Value","conceptCode":"C25712","definition":"A numerical quantity measured or assigned or computed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CEDDB0E9-ABD3-273E-E040-BB89AD430E35","latestVersionIndicator":"Yes","beginDate":"2012-11-19","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-11-19","modifiedBy":"ONEDATA","dateModified":"2012-11-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CEDDB0E9-ABE4-273E-E040-BB89AD430E35","latestVersionIndicator":"Yes","beginDate":"2012-11-19","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-11-19","modifiedBy":"COOPERM","dateModified":"2012-12-03","changeDescription":"Created for TCGA per request by A.Janning and released per TCGA approval. mc 12/3/12","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2756809","version":"1","longName":"TCGA (The Cancer Genome Atlas)","context":"NCIP","ClassificationSchemeItems":[{"publicId":"6044923","version":"1","longName":"Active CDEs as of March 2017","context":"NCIP"}]},{"publicId":"5806857","version":"1","longName":"HCMI (Human Cancer Models Initiative)","context":"OCG","ClassificationSchemeItems":[{"publicId":"5777527","version":"1","longName":"Pancreatic","context":"OCG"}]}],"AlternateNames":[{"name":"OCG","type":"USED_BY","context":"OCG"},{"name":"tumor_marker_CA-19-9_test_UNV","type":"HCMI Name","context":"OCG"}],"ReferenceDocuments":[{"name":"CA 19-9 Level Upper Limit of","type":"Preferred Question Text","description":"CA 19-9 Level Upper Limit of Normal Value","url":null,"context":"NCIP"}],"origin":"TCGA:The Cancer Genome Atlas","workflowStatus":"RELEASED","registrationStatus":"Application","id":"E83D3050-D962-9B8D-E040-BB89AD4306D2","latestVersionIndicator":"Yes","beginDate":"2013-10-08","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-10-08","modifiedBy":"TSESU","dateModified":"2018-07-16","changeDescription":"Created for Cholangiocarcinoma enrollment form per request by T.Lichtenberg. mc 10/8/13","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}